Screener
BPAY vs IHE
iShares FinTech Active ETF vs iShares U.S. Pharmaceuticals ETF
Key differences
- IHE costs 0.17% less per year.
- IHE is significantly larger than BPAY — larger funds tend to be more liquid and less likely to close.
- BPAY is classified as alternative, while IHE is equity — different risk/return profiles.
- BPAY covers global markets; IHE covers north america.
- BPAY follows a active selection strategy; IHE uses index tracking.
- Over the last 3 years, IHE has delivered higher annualized returns.
- IHE has a longer track record, which may reduce uncertainty around long-term behavior.
Side-by-side comparison
| BPAY | IHE | |
|---|---|---|
| Annual cost (TER) | 0.55% | 0.38% |
| Fund size (AUM) | $9M | $946M |
| Since | 2022 | 2006 |
| Dividend yield | 2.89% | 1.70% |
| Asset class | alternative | equity |
| Region | global | north america |
| Strategy | active selection | index tracking |
| CAGR 1Y | -5.8% | +46.2% |
| CAGR 3Y | +9.7% | +18.0% |
| CAGR 5Y | N/A | +10.1% |
| Sharpe 3Y | 0.36 | 0.87 |
| Volatility 1Y | 25.59% | 16.91% |
| Max drawdown | -33.62% | -29.59% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to BPAY and IHE
Explore further